Abstract:The expression and methylation of p15INK4B gene and the expression of DNA methyltransferase genes (DNMTs) in the mononuclear cells (MNCs) from bone marrow of 54 cases with hematopoietic malignances were detected by using RT-PCR, Western blot, and methylation-specific PCR. Of the 54 patients, 10 cases were low-risk MDS, 10 cases were high-risk MDS, 10 cases were acute myeloid leukemia (AML), 10 cases were acute lymphocytic leukemia (ALL), 10 cases were chronic myeloid leukemia in chronic phase (CML-CP), and 4 cases were CML in blast phase (CML-BP). 10 normal persons were studied as nective controls. The results showed that the incidence of p15INK4B methylation in cells of high-risk MDS was higher than that in low-risk MDS (6/10 VS 1/10, P=0.003), and the p15INK4B methylation was found to be associated with the down-regulation of the expressions of p15INK4B gene on both mRNA (r=−0.734, p<0.001) and protein (r=−0.664, p=0.001)levels, which indicated that the silencing of p15INK4B gene was in conjunction with hypermethylation in MDS. The expressions of p15INK4B on mRNA level and protein levels were almost detected in the MNCs from bone marrow of normal persons without the p15INK4B methylation. We also found the expression of DNMT3A and DNMT3B in high-risk MDS (densitometry readings respectively: 0.624±0.146, 0.577±0.344) were higher than in low-risk MDS (densitometry readings respectively: 0.487±0.300, 0.338±0.290) (P<0.05). The expression of DNMT1 was higher in the groups of low-risk MDS, high-risk MDS, AL and CML-CP( densitometry readings respectively: 0.487±0.218, 0.697±0.243, 0.706±0.463 and 0.867±0.375) than in normal control (densitometry reading: 0.181±0.312)(P<0.05, figure listed bellow), which indicated that up-regulated DNMTS might contribute to the hypermethylation of p15INK4B, and the higher expressions of de novo methyltransferases DNMT3A and DNMT3B may be related to the disease progression of MDS. The methylation of p15INK4B was also detected in 9/20 of AL cases accompanied by over-expressions of DNMT1, DNMT3A, and DNMT3B (densitometry readings respectively: 0.706±0.463, 1.066±0.547, and 0.530±0.428). The methylation of p15INK4B was detected in 1 of 10 cases of CML-CP patients, but all be detected in 4 case of CML-BP patients. These results indicated that the hypermethylation of p15INK4B gene may be one of the most common genetic event in pathogenesis of high-risk MDS, acute leukemia, and blast phase of CML. Furthermore, DNMT3A and DNMT3B were substantially over-expressed in the bone marrow cells of these patients. which might play an important role in the transformation from MDS to acute leukemia.

[Abnormality of P15(ink4b) Gene and Myelodysplastic Syndrome].

Study on Methylation of P15ink4b Gene and Its Mechanisms in Patients with Myelodysplastic Syndrome and Leukemia.

[Methylation of P15INK4B Gene in Patients with Myelodysplastic Syndromes and Demethylating Effects of Drugs].

Methylation status of p15~(INK4B) gene in patients with myelodysplastic syndromes

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

Role of p15(INK4B) Methylation in Patients With Myelodysplastic Syndromes: A Systematic Meta-Analysis

Effect of P15~(ink4b) Gene Methylation in Myelodysplastic Syndromes' Progressing:A Meta-analysis of Literature

To Investigate the Relationship Between P15INK4B Gene Promoter Methylation Degree and Different Types of MDS and Prognosis

Aberrant DNA Methylation Associated with Silencing BNIP3 Gene Expression in Haematopoietic Tumours

[Arsenic Trioxide Induced P15ink4b Gene Expression in Myelodysplastic Syndrome Cell Line MUTZ-1].

Aberrant Methylation Of Death-Associated Protein Kinase 1 Cpg Islands In Myelodysplastic Syndromes

[P15(ink4b) Methylation on Prognosis and Response to Decitabine in Patients with MDS].

[Detection of Methylation Levels of Multi-Genes by Real-Time PCR in Patients with Myelodysplastic Syndrome].

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.

Abnormalities of Tumor Suppressor Genes P16 and P15 in Primary Maxillofacial Squamous Cell Carcinomas

[The Re-Expression of P15(ink4b) Gene in Leukemia Cells Induced by in Vitro DNA Methyltransferase and Histone Deacetylase Inhibition].

Deletion of the P15 Gene and Promoter Methylation in the Bone Marrow of Patients with Myelodysplastic Syndromes

ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.

Cellular and Molecular Evidence for Malignancy-Inhibitory Functions of P15rs.

[Study of Aberrant P73 Promoter Methylation in Patients with Myelodysplastic Syndrome].

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis